| Variable | Arbitrary, No. (%) | P Value | |
|---|---|---|---|
| Yes | No | ||
| Gender | 0.001 | ||
| Male | 234 (82.7) | 49 (17.3) | |
| Female | 278 (95.9) | 12 (4.1) | |
| Grade | 0.146 | ||
| Bachelor | 146 (94.2) | 9 (5.8) | |
| Master of Science | 61 (88.4) | 8 (11.6) | |
| General practitioner | 289 (87.3) | 42 (12.7) | |
| Ph.D. | 14 (87.5) | 2 (12.5) | |
| College | 0.36 | ||
| Medicine | 199 (88.4) | 26 (11.6) | |
| Pharmacology | 50 (87.7) | 7 (12.3) | |
| Dentistry | 39 (83) | 8 (17) | |
| Health | 99 (91.7) | 9 (8.3) | |
| Nursing | 50 (96.2) | 2 (3.8) | |
| Paramedicine | 73 (98) | 9 (11) | |
| Father's education | 0.2 | ||
| High school | 78 (94) | 5 (6) | |
| Diploma | 137 (86.2) | 22 (13.8) | |
| Associate Degree | 36 (94.7) | 2 (5.3) | |
| Bachelor | 165 (89.7) | 19 (10.3) | |
| Master of Science | 54 (85.7) | 9 (14.3) | |
| Ph.D. | 28 (96.6) | 1 (3.4) | |
| Mother's education | 0.53 | ||
| High school | 129 (92.1) | 11 (7.9) | |
| Diploma | 169 (89.9) | 21 (11.1) | |
| Associate Degree | 28 (93.3) | 2 (6.7) | |
| Bachelor | 132 (86.3) | 21 (13.7) | |
| Master of Science | 28 (93.3) | 2 (6.7) | |
| Ph.D. | 10 (83.3) | 2 (16.7) | |
| Father's occupation | 0.6 | ||
| Governmental | 229 (90.9) | 23 (9.1) | |
| Non-governmental | 176 (88) | 24 (12) | |
| Others | 95 (88.8) | 12 (11.2) | |
| Mother's occupation | 0.008 | ||
| Housewife | 344 (90.8) | 35 (9.2) | |
| Governmental | 131 (89.1) | 16 (10.9) | |
| Others | 25 (73.5) | 6 (26.5) | |
| Smoking | 0.001 | ||
| Yes | 33 (51.6) | 31 (48.4) | |
| No | 479 (94.1) | 30 (5.9) | |
| Addiction | 0.001 | ||
| Yes | 9 (45) | 11 (55) | |
| No | 503 (91) | 50 (9) | |
| Ritalin use | 0.001 | ||
| Yes | 17 (47.2) | 19 (52.8) | |
| No | 495 (92.2) | 42 (7.8) | |
| Tramadol use | 0.001 | ||
| Yes | 9 (47.4) | 10 (52.6) | |
| No | 503 (90.8) | 51 (9.2) | |
| Inderal use | 0.014 | ||
| Yes | 24 (75) | 8 (25) | |
| No | 488 (90.2) | 53 (9.8) | |
Image Credit: International Journal of High Risk Behaviors and Addiction
Zolpidem Use Among Dormitory Students in Yazd, Iran
Authors
Acknowledgments
Footnotes
Authors' Contribution: Study concept and design: Mohammad Amin Afshoon, Saeed Hosseini, and Narjes Hazar; acquisition of data: Mohammad Amin Afshoon, and Narjes Hazar; analysis and interpretation of data: Vahid Rahmanian, Saeed Hosseini, and Narjes Hazar; drafting of the manuscript: Vahid Rahmanian, Saeed Hosseini, and Narjes Hazar; critical revision of the manuscript for important intellectual content: Vahid Rahmanian, Saeed Hosseini, Narjes Hazar, and Mahmood Vakili; statistical analysis: Mohammad Amin Afshoon, Saeed Hosseini, and Mahmood Vakili; administrative, technical, and material support: Mohammad Amin Afshoon, Saeed Hosseini, Narjes Hazar, Mahmood Vakili, and Vahid Rahmanian; study supervision: Narjes Hazar.
Conflict of Interests: The authors declare that there is no conflict of interest.
Ethical Approval: This study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Yazd University of Medical Sciences (project identification code: IR.SSU.MEDICINE.REC.1397.070).
Funding/Support: This project was financially supported by the Vice-Chancellor for Research of Shahid Sadoughi University of Medical Sciences.
References
- 1.Moore TJ, Mattison DR. Assessment of patterns of potentially unsafe use of zolpidem. JAMA Intern Med. 2018;178(9):1275-7. [PubMed ID: 30014137]. [PubMed Central ID: PMC6583219]. https://doi.org/10.1001/jamainternmed.2018.3031.
- 2.Kesselheim AS, Sinha MS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, et al. Multimodal analysis of FDA drug safety communications: Lessons from zolpidem. Drug Saf. 2019;42(11):1287-95. [PubMed ID: 31302895]. https://doi.org/10.1007/s40264-019-00849-8.
- 3.Netzel CL, Abd-Elsayed A. Benzodiazepines. Pain. Springer; 2019. p. 289-92. https://doi.org/10.1007/978-3-319-99124-5_63.
- 4.Jang Y, Song I, Oh IS, Shin JY. Twelve-year trend in the use of zolpidem and physicians' non-compliance with recommended duration: A Korean national health insurance database study. Eur J Clin Pharmacol. 2019;75(1):109-17. [PubMed ID: 30280207]. https://doi.org/10.1007/s00228-018-2563-9.
- 5.Mortaz Hejri S, Faizi M, Babaeian M. Zolpidem-induced suicide attempt: A case report. Daru. 2013;21(1):77. [PubMed ID: 24359886]. [PubMed Central ID: PMC3878174]. https://doi.org/10.1186/2008-2231-21-77.
- 6.Haji Seyed Javadi SA, Hajiali F, Nassiri-Asl M. Zolpidem dependency and withdrawal seizure: A case report study. Iran Red Crescent Med J. 2014;16(11). e19926. [PubMed ID: 25763219]. [PubMed Central ID: PMC4329938]. https://doi.org/10.5812/ircmj.19926.
- 7.Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Evidence of zolpidem abuse and dependence: Results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64(2):198-209. [PubMed ID: 17324242]. [PubMed Central ID: PMC2000636]. https://doi.org/10.1111/j.1365-2125.2007.02861.x.
- 8.Hsu J, Lin JJ, Tsay WI. Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011. J Food Drug Anal. 2014;22(2):169-77. https://doi.org/10.1016/j.jfda.2014.01.019.
- 9.Rahimi Pordanjani S, Fallah Zadeh H, Mousavi M, Khazaei S, Sohrabivafa M, Momenabadi V, et al. Prevalence and reasons for psychoactive drugs use among university students of medical sciences in Yazd, Iran. Iran J Psychiatr Behav Sci. 2018;12(1). e9384. https://doi.org/10.5812/ijpbs.9384.
- 10.Holm KJ, Goa KL. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59(4):865-89. [PubMed ID: 10804040]. https://doi.org/10.2165/00003495-200059040-00014.
Copyright
Copyright © 2020, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
Prevalence of Substance Abuse Among Dormitory Students of Shahid Beheshti University of Medical Sciences, Tehran, Iran
Babaei Heydarabadi A, Ramezankhani A, Barekati H, Vejdani M, Shariatinejad K, et al. Prevalence of Substance Abuse Among Dormitory Students of Shahid Beheshti University of Medical Sciences, Tehran, Iran. Int J High Risk Behav Addict. 2015;4(2):e22350. doi: https://doi.org/10.5812/ijhrba.22350v2
Prevalence and Reasons for Psychoactive Drugs Use Among University Students of Medical Sciences in Yazd, Iran
Rahimi Pordanjani S, Fallah Zadeh H, Mousavi M, Khazaei S, Sohrabivafa M, et al. Prevalence and Reasons for Psychoactive Drugs Use Among University Students of Medical Sciences in Yazd, Iran. Iran J Psychiatry Behav Sci. 2018;12(1):e9384. doi: https://doi.org/10.5812/ijpbs.9384
The Prevalence of Substance use and Associated Risk Factors Among University Students in the City of Jahrom, Southern Iran
Heydari ST, Izedi S, Sarikhani Y, Kalani N, Akbary A, et al. The Prevalence of Substance use and Associated Risk Factors Among University Students in the City of Jahrom, Southern Iran. Int J High Risk Behav Addict. 2015;4(2):e22381. doi: https://doi.org/10.5812/ijhrba.4(2)2015.22381
Drug Abuse among University Students of Rafsanjan, Iran
Rezahosseini O, Roohbakhsh A, Tavakolian V, Assar S. Drug Abuse among University Students of Rafsanjan, Iran. Iran J Psychiatry Behav Sci. 2014;8(2):. doi:
Patterns and Correlates of Substance Use Among University Students in Iran
Talaei A, Mokhber N, Fayyazi Bordbar MR, Javanbakh A, Samari AA. Patterns and Correlates of Substance Use Among University Students in Iran. Iran J Psychiatry Behav Sci. 2008;2(2):. doi:
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 1
Last Update: 2 days ago